Novoheart Holdings Company
Novoheart is committed to providing state-of-the-art stem cell and bioengineering approaches to revolutionize drug discovery.
Founded Date:
1964-01-01
Technology:
Biotechnology, Pharmaceutical
Funding Status:
IPO
Employee Number:
51-100
Headquarters:
Vancouver, Alberta, Canada
Industry:
Preclinical Development